In vivo studies demonstrated that reducing RBM5-AS1 levels suppresses tumor growth and enhances radiosensitivity, while its overexpression lessens radiation-triggered apoptosis and DNA damage in medulloblastoma cells through sirtuin 6 (SIRT6). The gene discussed is RBM5; the disease is medulloblastoma.